Premium
P3‐320: Molecular docking analysis of mitochondrial pyruvate carrier (MPC) 1 and 2 with pyruvate and inhibitors: Thiazolidinediones currently in clinical trials to delay mild cognitive impairment and Alzheimer's disease
Author(s) -
Phelix Clyde F.,
Perry George,
McHardy Stanton F.
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.1694
Subject(s) - autodock , docking (animal) , protein data bank (rcsb pdb) , chemistry , biochemistry , medicine , in silico , nursing , gene
Figure 1. Pyru Note cysteine r (IMM) where is facing the m MITOCHONDRIAL PYRUVATE CARRIER (MPC) 1 AND 2 WITH PYRUVATE AND INHIBITORS: THIAZOLIDINEDIONES CURRENTLY IN CLINICAL TRIALS TO DELAY MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE Clyde F. Phelix, George Perry, Stanton F. McHardy, The University of Texas at San Antonio, San Antonio, TX, USA; AL Phahelix Biometrics, Inc., San Antonio, TX, USA. Contact e-mail: clyde.phelix@utsa.edu